ClinConnect ClinConnect Logo
Search / Trial NCT03113552

Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Apr 10, 2017

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is examining how the location of mitral valve prolapse (a condition where the mitral valve does not close properly) affects the long-term success of a surgical procedure called mitral plasty. Mitral valve prolapse can lead to a condition called mitral insufficiency, where the heart cannot pump blood effectively. The researchers want to understand how different types of prolapse—whether it's on one part of the valve or both—impact the outcomes of the surgery.

To participate in this study, patients must have undergone mitral surgery between 1988 and 2011 and have been diagnosed with mitral valve prolapse through an ultrasound of the heart. Those with certain heart conditions or previous heart surgeries will not be eligible. If you join the study, you can expect to provide information about your health and the surgery you had, helping researchers learn more about the best treatment approaches for this condition. This trial is currently looking for participants of all genders, aged 65 and older.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients operated between 1988 and 2011
  • Presence of a valvular prolapse diagnosed by echocardiography
  • Possibility of a complete clinical evaluation at the time of the initial echocardiography
  • Exclusion Criteria:
  • Ischemic MI (including papillary muscle rupture)
  • Presence of significant aortic valvulopathy, mitral valvular stenosis or congenital disease
  • History of cardiac surgery

About Centre Hospitalier Universitaire, Amiens

The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.

Locations

Amiens, Picardie, France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials